ARTICLE | Company News
Aptuit, BioVersys deal
March 17, 2017 4:24 PM UTC
Aptuit partnered with BioVersys to discover and validate targets in Gram-negative bacteria. Aptuit will provide in vitro and in vivo discovery services. BioVersys will contribute an undisclosed target...